by Dan Roberts February 2, 2012 StemCells, Inc. announced on February 2, 2012 that the FDA has authorized a Phase I/II clinical trial of a new method using stem cells from the brain to prevent degeneration of the macula in dry AMD patients. Purified human neural stem cells (HuCNS-SC) will be administered by a single [Read More]
News
Degenerative Myopia: a Review of its Nature and Current Treatment
by Brian Ward, Ph.D., M.D. December 2011 Degenerative myopia deserves our recognition as one of the truly neglected areas of ophthalmology. It is reported to be the seventh ranking cause of legal blindness in the United Sates of America the fourth ranking cause in Hong Kong and the second in parts of China and Japan. [Read More]
An Examination of Sensory Contributions to Independent Activities of Daily Living
This paper is in PDF format. To download it, select this link.
Artificial Lighting and the Blue Light Hazard
(The Facts About Lighting and Vision) by Dan Roberts, Founding Director Macular Degeneration Support Originally published on MDSupport, updated October 3, 2011) Contents Introduction What Is Light? The Blue Light Hazard Terms Referring to Measurement of Light Types of Lamps The Problem With Full-Spectrum Lamps Market Survey Summary Discussion Safe Options Live Comparison of Representative [Read More]
AMD Report From ARVO 2011
by Dan Roberts It is important to note at the outset of this report that patients are highly respected across the professional board for their willingness to act as pioneers in the ongoing research. Our participation in clinical trials is greatly appreciated by the researchers. That having been said, here are latest updates on research [Read More]